Artykuły udostępnione publicznie: - Christopher I. LiWięcej informacji
Niedostępne w żadnym miejscu: 2
Sprawdź
AACR cancer progress report 2013
CL Sawyers, C Abate-Shen, KC Anderson, A Barker, J Baselga, ...
Clinical Cancer Research 19 (20 Supplement), S1-S98, 2013
Upoważnienia: US National Institutes of Health
Sprawdź
Obstetric Outcomes in Young Women with Breast Cancer: Prior, Postpartum, and Subsequent Pregnancies
KK Ma, CJ Preusse, PA Stevenson, VL Winget, JA McDougall, CI Li, ...
American journal of perinatology 37 (04), 370-374, 2020
Upoważnienia: US National Institutes of Health
Dostępne w jakimś miejscu: 131
Sprawdź
US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status
N Howlader, SF Altekruse, CI Li, VW Chen, CA Clarke, LAG Ries, ...
JNCI: Journal of the National Cancer Institute 106 (5), 2014
Upoważnienia: US National Institutes of Health
Sprawdź
Discovery of common and rare genetic risk variants for colorectal cancer
JR Huyghe, SA Bien, TA Harrison, HM Kang, S Chen, SL Schmit, ...
Nature genetics 51 (1), 76-87, 2019
Upoważnienia: US National Institutes of Health, Cancer Research UK, UK Medical Research …
Sprawdź
Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis
N Papadimitriou, N Dimou, KK Tsilidis, B Banbury, RM Martin, SJ Lewis, ...
Nature communications 11 (1), 1-10, 2020
Upoważnienia: US National Institutes of Health, Cancer Research UK, National Institute for …
Sprawdź
Disparities in breast cancer characteristics and outcomes by race/ethnicity
SL Ooi, ME Martinez, CI Li
Breast cancer research and treatment 127 (3), 729-738, 2011
Upoważnienia: US National Institutes of Health
Sprawdź
Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer
AI Phipps, RT Chlebowski, R Prentice, A McTiernan, J Wactawski-Wende, ...
Journal of the National Cancer Institute 103 (6), 470-477, 2011
Upoważnienia: US National Institutes of Health
Sprawdź
Body size, physical activity, and risk of triple-negative and estrogen receptor–positive breast cancer
AI Phipps, RT Chlebowski, R Prentice, A McTiernan, ML Stefanick, ...
Cancer Epidemiology and Prevention Biomarkers 20 (3), 454-463, 2011
Upoważnienia: US National Institutes of Health
Sprawdź
Recent oral contraceptive use by formulation and breast cancer risk among women 20 to 49 years of age
EF Beaber, DSM Buist, WE Barlow, KE Malone, SD Reed, CI Li
Cancer research 74 (15), 4078-4089, 2014
Upoważnienia: US National Institutes of Health
Sprawdź
Charting the future of cancer health disparities research: a position statement from the American Association for Cancer Research, the American Cancer Society, the American …
BN Polite, LL Adams-Campbell, OW Brawley, N Bickell, JM Carethers, ...
Cancer research 77 (17), 4548-4555, 2017
Upoważnienia: US National Institutes of Health
Sprawdź
Association of digital breast tomosynthesis vs digital mammography with cancer detection and recall rates by age and breast density
EF Conant, WE Barlow, SD Herschorn, DL Weaver, EF Beaber, ...
JAMA oncology 5 (5), 635-642, 2019
Upoważnienia: US National Institutes of Health
Sprawdź
Relationship between potentially modifiable lifestyle factors and risk of second primary contralateral breast cancer among women diagnosed with estrogen receptor–positive …
CI Li, JR Daling, PL Porter, MTC Tang, KE Malone
Journal of Clinical Oncology 27 (32), 5312, 2009
Upoważnienia: US National Institutes of Health
Sprawdź
Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women's health initiative observational study
CI Li, RT Chlebowski, M Freiberg, KC Johnson, L Kuller, D Lane, L Lessin, ...
Journal of the National Cancer Institute 102 (18), 1422-1431, 2010
Upoważnienia: US National Institutes of Health
Sprawdź
Reproductive and hormonal risk factors for postmenopausal luminal, HER‐2‐overexpressing, and triple‐negative breast cancer
AI Phipps, KE Malone, PL Porter, JR Daling, CI Li
Cancer: Interdisciplinary International Journal of the American Cancer …, 2008
Upoważnienia: US National Institutes of Health
Sprawdź
Novel common genetic susceptibility loci for colorectal cancer
SL Schmit, CK Edlund, FR Schumacher, J Gong, TA Harrison, JR Huyghe, ...
JNCI: Journal of the National Cancer Institute 111 (2), 146-157, 2019
Upoważnienia: US National Institutes of Health, National Health and Medical Research …
Sprawdź
Racial disparities in breast cancer diagnosis and treatment by hormone receptor and HER2 status
L Chen, CI Li
Cancer Epidemiology and Prevention Biomarkers 24 (11), 1666-1672, 2015
Upoważnienia: US National Institutes of Health
Sprawdź
Genome-wide modeling of polygenic risk score in colorectal cancer risk
M Thomas, LC Sakoda, M Hoffmeister, EA Rosenthal, JK Lee, ...
The American Journal of Human Genetics 107 (3), 432-444, 2020
Upoważnienia: US National Institutes of Health, Cancer Research UK
Sprawdź
Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20–44 years of age
CI Li, EF Beaber, MTC Tang, PL Porter, JR Daling, KE Malone
Breast cancer research and treatment 137 (2), 579-587, 2013
Upoważnienia: US National Institutes of Health
Sprawdź
Cumulative Burden of Colorectal Cancer–Associated Genetic Variants Is More Strongly Associated With Early-Onset vs Late-Onset Cancer
AN Archambault, YR Su, J Jeon, M Thomas, Y Lin, DV Conti, AK Win, ...
Gastroenterology 158 (5), 1274-1286. e12, 2020
Upoważnienia: US National Institutes of Health, Cancer Research UK, UK Medical Research …
Sprawdź
Insurance status and risk of cancer mortality among adolescents and young adults
AR Rosenberg, L Kroon, L Chen, CI Li, B Jones
Cancer 121 (8), 1279-1286, 2015
Upoważnienia: US National Institutes of Health
Informacje na temat publikacji i finansowania automatycznie określa program komputerowy